» Articles » PMID: 26846140

The Effects of Ellagic Acid Upon Brain Cells: A Mechanistic View and Future Directions

Overview
Journal Neurochem Res
Specialties Chemistry
Neurology
Date 2016 Feb 6
PMID 26846140
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Ellagic acid (EA, 2,3,7,8-tetrahydroxy-chromeno; C14H6O8) is a polyphenol derived from fruits (pomegranates, berries) and nuts. EA exhibits antioxidant capacity and induces anti-inflammatory actions in several mammalian tissues. EA has been characterized as a possible neuroprotective agent, but the number of reports is still limited to conclude whether and how EA exerts neuroprotection in humans. In this regard, performing additional studies considering the potential beneficial and/or toxicological roles for EA on brain cells would be an important step towards fully understanding of when and how EA may be securely utilized by humans as a neuroprotective agent. The aim of the present work is to discuss data related to the neuronal and glial effects of EA and the mechanisms underlying such events. Moreover, future directions are suggested as a potential guide to be utilized by researchers interested in investigating the neuronal and glial actions of EA hereafter.

Citing Articles

Targeting natural antioxidant polyphenols to protect neuroinflammation and neurodegenerative diseases: a comprehensive review.

Jalouli M, Rahman M, Biswas P, Rahman H, Harrath A, Lee I Front Pharmacol. 2025; 16:1492517.

PMID: 39981183 PMC: 11840759. DOI: 10.3389/fphar.2025.1492517.


Exploring the synergistic potential of pomegranate fermented juice compounds against oxidative stress-induced neurotoxicity through computational docking and experimental analysis in human neuroblastoma cells.

Akter R, Morshed M, Awais M, Kong B, Oh S, Oh J Heliyon. 2024; 10(15):e34993.

PMID: 39157308 PMC: 11327604. DOI: 10.1016/j.heliyon.2024.e34993.


A Critical Appraisal of the Protective Activity of Polyphenolic Antioxidants against Iatrogenic Effects of Anticancer Chemotherapeutics.

Purgatorio R, Boccarelli A, Pisani L, De Candia M, Catto M, Altomare C Antioxidants (Basel). 2024; 13(1).

PMID: 38275658 PMC: 10812703. DOI: 10.3390/antiox13010133.


Ellagic acid alleviates motor, cognitive and hippocampal electrical activity deficits in the male rats with 2-vessel occlusion cerebral ischemia/reperfusion.

Hassonizadeh Falahieh K, Sarkaki A, Edalatmanesh M, Gharib Naseri M, Farbood Y Avicenna J Phytomed. 2023; 13(6):651-664.

PMID: 38106628 PMC: 10719720. DOI: 10.22038/AJP.2023.22787.


Synthetic and Natural Bioactive Molecules in Balancing the Crosstalk among Common Signaling Pathways in Alzheimer's Disease: Understanding the Neurotoxic Mechanisms for Therapeutic Intervention.

Shah A, Ahad Mir P, Adnan M, Patel M, Maqbool M, Mir R ACS Omega. 2023; 8(43):39964-39983.

PMID: 37929080 PMC: 10620788. DOI: 10.1021/acsomega.3c05662.


References
1.
Salimi A, Roudkenar M, Sadeghi L, Mohseni A, Seydi E, Pirahmadi N . Ellagic acid, a polyphenolic compound, selectively induces ROS-mediated apoptosis in cancerous B-lymphocytes of CLL patients by directly targeting mitochondria. Redox Biol. 2015; 6:461-471. PMC: 4588415. DOI: 10.1016/j.redox.2015.08.021. View

2.
Green D, Galluzzi L, Kroemer G . Cell biology. Metabolic control of cell death. Science. 2014; 345(6203):1250256. PMC: 4219413. DOI: 10.1126/science.1250256. View

3.
Sompol P, Xu Y, Ittarat W, Daosukho C, St Clair D . NF-kappaB-associated MnSOD induction protects against beta-amyloid-induced neuronal apoptosis. J Mol Neurosci. 2006; 29(3):279-88. View

4.
Arulmozhi V, Pandian K, Mirunalini S . Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB). Colloids Surf B Biointerfaces. 2013; 110:313-20. DOI: 10.1016/j.colsurfb.2013.03.039. View

5.
Anitha P, Vidya Priyadarsini R, Kavitha K, Thiyagarajan P, Nagini S . Ellagic acid coordinately attenuates Wnt/β-catenin and NF-κB signaling pathways to induce intrinsic apoptosis in an animal model of oral oncogenesis. Eur J Nutr. 2011; 52(1):75-84. DOI: 10.1007/s00394-011-0288-y. View